Scholars@Duke

Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines.

Publication ,  Journal Article
Tempero, MA; Arnoletti, JP; Behrman, SW; Ben-Josef, E; Benson, AB; Casper, ES; Cohen, SJ; Czito, B; Ellenhorn, JDI; Hawkins, WG; Herman, J ...
Published in: J Natl Compr Canc Netw
June 1, 2012
Published version (DOI) Link to item

The NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines) for Pancreatic Adenocarcinoma discuss the workup and management of tumors of the exocrine pancreas. These NCCN Guidelines Insights provide a summary and explanation of major changes to the 2012 NCCN Guidelines for Pancreatic Adenocarcinoma. The panel made 3 significant updates to the guidelines: 1) more detail was added regarding multiphase CT techniques for diagnosis and staging of pancreatic cancer, and pancreas protocol MRI was added as an emerging alternative to CT; 2) the use of a fluoropyrimidine plus oxaliplatin (e.g., 5-FU/leucovorin/oxaliplatin or capecitabine/oxaliplatin) was added as an acceptable chemotherapy combination for patients with advanced or metastatic disease and good performance status as a category 2B recommendation; and 3) the panel developed new recommendations concerning surgical technique and pathologic analysis and reporting.

Duke Scholars

Brian Gary Czito
Author Brian Gary Czito Radiation Oncology
Jorge Valdemar Obando
Author Jorge Valdemar Obando Medicine, Gastroenterology
Altmetric Attention Stats
Dimensions Citation Stats

Published In

J Natl Compr Canc Netw

DOI

10.6004/jnccn.2012.0073

EISSN

1540-1413

Publication Date

June 1, 2012

Volume

10

Issue

6

Start / End Page

703 / 713

Location

United States

Related Subject Headings

  • Pancreatic Neoplasms
  • Oncology & Carcinogenesis
  • Neoplasm Staging
  • Humans
  • Diagnostic Imaging
  • Antineoplastic Combined Chemotherapy Protocols
  • Adenocarcinoma
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Tempero, M. A., Arnoletti, J. P., Behrman, S. W., Ben-Josef, E., Benson, A. B., Casper, E. S., … National Comprehensive Cancer Networks. (2012). Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw, 10(6), 703–713. https://doi.org/10.6004/jnccn.2012.0073
Tempero, Margaret A., J Pablo Arnoletti, Stephen W. Behrman, Edgar Ben-Josef, Al B. Benson, Ephraim S. Casper, Steven J. Cohen, et al. “Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines.” J Natl Compr Canc Netw 10, no. 6 (June 1, 2012): 703–13. https://doi.org/10.6004/jnccn.2012.0073.
Tempero MA, Arnoletti JP, Behrman SW, Ben-Josef E, Benson AB, Casper ES, et al. Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw. 2012 Jun 1;10(6):703–13.
Tempero, Margaret A., et al. “Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines.” J Natl Compr Canc Netw, vol. 10, no. 6, June 2012, pp. 703–13. Pubmed, doi:10.6004/jnccn.2012.0073.
Tempero MA, Arnoletti JP, Behrman SW, Ben-Josef E, Benson AB, Casper ES, Cohen SJ, Czito B, Ellenhorn JDI, Hawkins WG, Herman J, Hoffman JP, Ko A, Komanduri S, Koong A, Ma WW, Malafa MP, Merchant NB, Mulvihill SJ, Muscarella P, Nakakura EK, Obando J, Pitman MB, Sasson AR, Tally A, Thayer SP, Whiting S, Wolff RA, Wolpin BM, Freedman-Cass DA, Shead DA, National Comprehensive Cancer Networks. Pancreatic Adenocarcinoma, version 2.2012: featured updates to the NCCN Guidelines. J Natl Compr Canc Netw. 2012 Jun 1;10(6):703–713.

Published In

J Natl Compr Canc Netw

DOI

10.6004/jnccn.2012.0073

EISSN

1540-1413

Publication Date

June 1, 2012

Volume

10

Issue

6

Start / End Page

703 / 713

Location

United States

Related Subject Headings

  • Pancreatic Neoplasms
  • Oncology & Carcinogenesis
  • Neoplasm Staging
  • Humans
  • Diagnostic Imaging
  • Antineoplastic Combined Chemotherapy Protocols
  • Adenocarcinoma
  • 4203 Health services and systems
  • 3211 Oncology and carcinogenesis